Samenvatting
Disease activity of acromegaly can be measured in many ways. Growth hormone (GH) and insulin-like growth factor 1 (IGF1) concentrations are the main biochemical markers used to measure the response to treatment. Both GH and IGF1 have been associated with prognosis, in particular mortality. In this review, we discuss the available parameters to assess disease activity in acromegaly.
| Originele taal-2 | Engels |
|---|---|
| Pagina's (van-tot) | 609-614 |
| Aantal pagina's | 6 |
| Tijdschrift | Clinical endocrinology |
| Volume | 76 |
| Nummer van het tijdschrift | 5 |
| DOI's | |
| Status | Gepubliceerd - mei 2012 |
| Extern gepubliceerd | Ja |
Vingerafdruk
Duik in de onderzoeksthema's van 'What is active acromegaly and which parameters do we have?'. Samen vormen ze een unieke vingerafdruk.Citeer dit
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver